India’s biotechnology sector has grown substantially over the past ten years, increasing from around $10 billion to over $195 billion, according to Jitendra Singh.
Speaking at the 14th Foundation Day of Biotechnology Industry Research Assistance Council (BIRAC), Singh attributed this expansion to a supportive policy framework, sustained government backing, and stronger collaboration between the public and private sectors since 2014.
He noted that BIRAC has developed into a key institution that enables structured and outcome-focused partnerships between industry and academia, replacing earlier fragmented approaches.
Singh highlighted that the sector has continued to grow despite challenges such as the COVID-19 pandemic, along with financial and technical constraints. He added that risk and failure are inherent aspects of scientific innovation, and progress depends on persistence despite these challenges.
He also underlined the importance of resilience, stating that India’s biotech progress reflects its ability to advance under difficult conditions. According to him, the country’s innovation ecosystem and skilled workforce are contributing to its broader economic ambitions.
Singh further said that BIRAC has played an important role by facilitating targeted funding, mentorship, incubation support, and stronger industry-academia linkages, which have collectively driven innovation in the biotech sector.
